Brief: BioInvent Gets FDA Fast Track Designation For BI-1808
07/08/2026 14:04
BRIEF-BioInvent Gets FDA Fast Track Designation For BI-1808 Aug 7 (Reuters) - BioInvent International AB BINV.ST:
BIOINVENT RECEIVES U.S. FOOD AND DRUG ADMINISTRATION (FDA) FAST TRACK DESIGNATION FOR BI-1808 FOR THE TREATMENT OF OVARIAN CANCER
Source text: ID:nMFN467wWp
Further company coverage: BINV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))